Korean (137/163) |
rs1544410 A |
GG vs GA+AA |
0.917 |
0.438–1.919 |
0.818 |
No significant difference for BsmI |
[26] |
|
rs731236 C |
TT vs TC+CC |
1.390 |
0.680-2.842 |
0.366 |
No
significant difference for TaqI |
|
|
rs7976091T |
CC vs CT+TT |
1.574 |
0.961-2.579 |
0.071 |
No
significant difference for ApaI |
|
|
rs2228570 T |
CC vs CT+TT |
0.826 |
0.506-1.347 |
0.443 |
No
significant difference for FokI |
|
Chinese
(470/470)
|
rs2228570
|
A vs G
|
1.289
|
1.074-1.547
|
0.006
|
Significant; increased risk for A allele
|
[27]
|
|
|
AA vs GG+GA |
1.707 |
1.239-2.353 |
0.001 |
|
|
|
|
AA vs GG |
1.741 |
1.201-2.524 |
0.003 |
|
|
Chinese (260/282) |
FokI |
C allele |
1.340 |
1.044-1.720 |
0.023 |
Significant association in PD |
[28] |
|
|
CC+TC vs TT |
2.164 |
1.264-3.703 |
0.004 |
Significant difference
between patient and control |
|
|
|
CC vs CT+TT |
1.139 |
0.880-1.331 |
0.223 |
|
|
|
BsmI |
AA+AG vs GG |
1.099 |
0.677-1.785 |
0.712 |
No significant
difference |
|
|
|
AA vs AG +GG |
2.188 |
0.397-10.04 |
0.434 |
|
|
Iran 150/160 |
ApaI |
TG+GG |
7.7 |
3.2-18.38 |
<0.0001 |
TG
genotype significantly increased in PD |
[29] |
|
FokI |
TT+CT |
7.7 |
3.2-18.38 |
0.85 |
No difference between PD and
control |
|
Faroese 121/231 |
ApaI rs7975232 |
AC |
1.14 |
0.67-1.92 |
0.64 |
No
significant association between VDR polymorphism in PD patients |
[30] |
|
|
CC |
1.31 |
0.70-2.50 |
0.40 |
|
|
|
|
AC+CC |
1.19 |
0.72-2.0 |
0.50 |
|
|
|
|
A |
1.14 |
0.83-1.56 |
0.41 |
|
|
|
BsmI rs1544410 |
AG |
1.3 |
0.78-2.04 |
0.34 |
No significant
association between VDR polymorphism in PD patients |
|
|
|
AA |
0.97 |
0.50-1.87 |
0.93 |
|
|
|
|
AG+AA |
1.18 |
0.75-1.86 |
0.47 |
|
|
|
|
G |
1.04 |
0.76-1.43 |
0.81 |
|
|
|
TaqI |
CT |
1.28 |
0.79-2.01 |
0.32 |
No significant association
between VDR polymorphism in PD patients |
|
|
|
CC |
0.99 |
0.51-1.90 |
0.97 |
|
|
|
|
CT+CC |
1.2 |
0.76-1.90 |
0.43 |
|
|
|
|
T |
1.05 |
0.76-1.44 |
0.77 |
|
|
Taiwanese 700/792 |
rs2853599 |
AA+GA vs GG |
0.85 |
0.68-1.06 |
0.16 |
No significant association between VDR polymorphism in PD patients |
[31] |
|
rs4334089 |
AA+GA vs GG |
1.06 |
0.86-1.31 |
0.57 |
|
|
|
rs7299460 |
TT+CT vs CC |
1.12 |
0.89-1.42 |
0.33 |
|
|
|
rs7968585 |
CC+CT vs TT |
1.02 |
0.83-1.25 |
0.86 |
|
|
|
rs7976091 |
TT+CT vs CC |
0.92 |
0.73-1.16 |
0.49 |
|
|
|
rs10083198 |
CT+TT vs CC |
1.07 |
0.86-1.33 |
0.57 |
|
|
Japanese 137/none |
FokI |
CC vs CT + TT |
0.33 |
0.17-0.67 |
0.002 |
FokICC linked with PD onset |
[32] |
|
BsmI |
AA vs AG+ GG |
0.34 |
0.09-1.29 |
0.11 |
No significant
difference for BsmI |
|
|
ApaI |
GG vs GT+TT |
1.23 |
0.63-2.43 |
0.55 |
No significant
difference for ApaI |
|
|
TaqI |
TT vs TC + CC |
1.570 |
0.70-3.53 |
0.23 |
No significant
difference for TaqI |
|
Hungarian |
FokI |
CC+CT vs TT |
2.677 |
1.214-5.91 |
0.015 |
Significantly higher in PD patients than control |
[33] |
|
|
C allele |
1.615 |
1.087-2.399 |
0.017 |
Significant association
with PD group. |
|
|
BsmI |
GG vs AA+AG |
0.890 |
0.478-1.654 |
0.753 |
No significant
difference between patient and control |
|
|
|
Allele frequency |
0.977 |
0.665-1.434 |
0.905 |
|
|
|
TaqI |
TT+TC vs CC |
0.840 |
0.399-1.767 |
0.646 |
No significant
difference between patient and control |
|
|
|
Allele frequency |
0.802 |
0.540-1190 |
0.273 |
|
|
|
ApaI |
GG vs TT+TG |
1.352 |
0.654-2.796 |
0.466 |
No significant
difference between patient and control |
|
|
|
Allele frequency |
1.177 |
0.793-1.748 |
0.417 |
|
|